Study of Cushing's Syndrome Not Related to ACTH Production
NCT00006278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2008-03-04
Summary
This study is designed to provide information about the cause of two unusual types of Cushing's syndrome and to evaluate quality of life before and after cure of the disease. In Cushing's syndrome, the adrenal glands produce too much of the hormone cortisol. This often causes weight gain, skin changes (bruising and stretch marks), and mood changes such as irritability, easy crying and depression. Adrenocorticotrophic hormone (ACTH) normally regulates cortisol production; when cortisol is low, ACTH rises, stimulating the adrenals to produce more cortisol, and when cortisol is high, ACTH levels fall. In two forms of Cushing's syndrome, however, the adrenal glands produce cortisol even when ACTH is low.
Patients 18 years of age and older with Cushing's syndrome not related to ACTH production may participate in this study. Candidates will be have a history and physical examination, electrocardiogram, urine, blood and saliva tests, and a computerized tomography (CT) scan of one or both adrenal glands. They will fill out questionnaires on their disease symptoms, quality of life, and on basic information about themselves, such as marital status, education level, place of residence, etc. Finally, they will have a corticotropin-releasing hormone (CRH) test to confirm that they have the form of Cushing's syndrome under study in this protocol. This test involves collecting blood samples at intervals before and after administration of sheep CRH to measure cortisol and ACTH levels.
Participants will undergo 3 to 7 days of testing to determine if their cortisol level rises after taking certain medicines or eating certain foods. These foods and medicines, chosen to mimic or stimulate substances already in the body, are: glucagon, ACTH, gonadotropin-releasing hormone, vasopressin, thyrotropin-releasing hormone, and a mixed meal consisting of a protein, carbohydrate and fat (usually chicken breast and a milkshake-like drink). Blood will be collected at intervals before and after taking the food or medicine to measure cortisol blood levels. Blood will also be collected while the patient is in a standing position and while lying in bed, because changes in posture can cause substances in the body to increase or decrease. Depending on the individual's response to these tests, additional tests may be done with insulin, glucose, luteinizing hormone and follicle-stimulating hormone.
Patients who do not respond to these substances will undergo adrenalectomy (surgery to remove one or both adrenal glands). This is standard treatment for this type of Cushing's syndrome. It is usually done by laparoscopy, in which air is injected into the abdomen through tubes inserted through a small incision, enabling the surgeon to see the organs and remove the gland. Part of the removed tissue will be examined to learn about what causes this type of Cushing's syndrome; it may also be used for genetic studies related to the disease. Patients will stay in the hospital for a week to 10 days for observation and treatment and then will be discharged to the care of their own doctor. They will continue to complete the quality of life questionnaire every 3 months for 2 years.
Patients with normal adrenal glands who are participating in National Cancer Institute studies and are scheduled for adrenalectomy as part of their standard treatment will also be recruited for this study to serve as controls. The patients will have a 24-hour urine collection, and part of the adrenal gland tissue removed for their treatment will be used for research purposes of this study, possibly including genetic study.
Conditions
- Cushing's Syndrome
- Healthy
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Completion
- 2002-09-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Adrenal Gland Tumors
NCT00005927 ·Status: COMPLETED
-
Examining Genetic Differences Among People With 21-Hydroxylase Deficiency
NCT00542841 ·Status: COMPLETED ·Phase: NA
-
Study of UK Adults With Congenital Adrenal Hyperplasia.
NCT00749593 ·Status: COMPLETED
-
Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease
NCT00590018 ·Status: COMPLETED ·Phase: PHASE2
-
Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia
NCT00011791 ·Status: COMPLETED
-
Availability Study of ACTH to Treat Children SRNS/SDNS
NCT02972346 ·Status: UNKNOWN ·Phase: NA
-
Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
NCT00932932 ·Status: COMPLETED
-
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004669 ·Status: COMPLETED ·Phase: PHASE2
-
Neuroendocrine Dysfunction in Critically Ill Pediatric Patients
NCT00207896 ·Status: COMPLETED
-
Steroid Panel for One-step Diagnosis of Adrenal Diseases
NCT04948970 ·Status: COMPLETED
-
Diagnosis of Pheochromocytoma
NCT00004847 ·Status: RECRUITING ·Phase: PHASE1
-
Factors of Steroid Dependency in Idiopathic Nephrotic Syndrome
NCT01609426 ·Status: COMPLETED
-
Clinical Studies of Progeria
NCT00094393 ·Status: COMPLETED
-
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
NCT02368379 ·Status: COMPLETED ·Phase: NA
-
Diagnosis and Treatment of Pheochromocytoma
NCT00001229 ·Status: COMPLETED
-
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
NCT06344143 ·Status: RECRUITING
-
Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
NCT01839812 ·Status: COMPLETED ·Phase: PHASE1
-
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
NCT00000102 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
NCT02225860 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Development of Health-related Quality of Life Instrument for Patients With Cystinosis
NCT05959668 ·Status: RECRUITING
-
Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
NCT02132195 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Biomarkers in Alpha-mannosidosis
NCT02141503 ·Status: COMPLETED
-
Study of Alpha-blockers Alone During Preoperative Preparation in Patients With Pheochromocytoma
NCT05803330 ·Status: COMPLETED ·Phase: NA
-
Circadian Rhythm Deregulation in Patients With CAPS
NCT06544018 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for Feeding Intolerance in Infants With Complex Congenital Heart Defects Undergoing Single Ventricle Staged Palliation
NCT02995577 ·Status: UNKNOWN